<DOC>
	<DOC>NCT00933686</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of recombinant human growth hormone (r-hGH) treatment in severe fibromyalgia subjects with growth axis dysfunction.</brief_summary>
	<brief_title>Growth Hormone in Neuroendocrine Dysfunction With Severe Fibromyalgia Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Women aged greater than or equal (&gt;=) 18 years Fibromyalgia diagnosed at least one year before History of generalized pain and at least 16 positive tender points (1990 American College of Rheumatology [ACR] criteria) Body Mass Index (BMI) less than or equal to(=&lt;) 32 Normal GH stimulation test (insulin) Stable (&gt;= 3 months unchanged) standard treatment with amitriptyline (1050 milligram per day [mg/day]) plus selective serotonin reuptake inhibitor (1040 mg/day) plus tramadol (25400 mg/day) Active rehabilitation program during the previous year (at least 30 minutes/day) Fibromyalgia Impact Questionnaire (FIQ) score &gt;=75 IGF1 serum level =&lt; 150 nanogram/milliliter (ng/mL) otherwise =&lt; 2 SD of the local lab normality) Normal response to IGF1 generation test Chronic Fatigue Symptoms (Multidimensional Assessment of Fatigue [MAF]) Effective anticonception Willingness to comply with the protocol Written Informed consent Major psychiatric condition Rheumatic disease, including systemic lupus erythematosus (SLE) Previous or current malignancies, active or inactive Clinical history intracranial space occupying lesion Reactive or secondary (rheumatoid arthritis [RA], osteoarthritis) fibromyalgia syndrome (FMS) Antinuclear antibody (ANA) greater than or equal 1:80 Abnormal Creatine phosphokinase (CPK) or aldolase serum levels Not controlled thyroid disease in the last 3 months (free Thyroxine [T4] and Thyrotrophinstimulating hormone [TSH] serum levels) Diabetes mellitus Adrenal gland disease (any abnormal cortisolemia, will be confirmed by 24hour cortisoluria) Pregnancy or breast feeding Known to be hypersensitive to somatotropin or any of the excipients</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>